Table 1 Clinical and serological characteristics of patients with proven invasive candidiasis (group 1).

1

Polytraumatized suprarenal insuficiency

C. albicans

+

5120

+

2

Bladder surgery

C. albicans

+

20480

+

3

Abdominal surgery, Crohn's disease

C. albicans

-

1280

+

4

Polytraumatized

C. albicans

-

1280

+

5

Heart surgery, mediastinitis

C. tropicalis

-

160

+

6

Pneumonia

C. utilis

-

1280

+

7

Guillain-Barré syndrome

C. albicans

+

20480

+

8

Polytraumatized

C. albicans

+

5120

+

9

Abdominal surgery

C. tropicalis

-

160

+

10

Abdominal surgery

C. albicans

-

1280

-

11

Pancreatitis

C. glabrata and C. albicans

+

1280

+

12

Abdominal surgery

C. albicans

+

5120

+

13

Colon surgery

C. albicans

-

640

+

14

HIV

C. dubliniensis

-

320

+

15

Abdominal surgery

C. parapsilosis

-

640

+

16

Pneumonia

C. parapsilosis

-

80

+

17

Pancreatitis

C. glabrata

+

640

+

18

Asthma

C. parapsilosis

-

320

+

19

Intestinal occlusion

C. albicans

-

20

+

20

Cirrhosis, hepatitis B

C. albicans

-

1280

+

21

Abdominal surgery, ulcerative colitis

C. albicans

+

320

+

22

Surgery, ulcerative colitis

C. albicans

-

640

+

23

Surgery, ulcerative colitis

C. guilliermondii

-

20

-

24

Rheumatoid arthritis, immunosuppressors

C. parapsilosis

-

320

+

25

Renal transplant, immunosuppressors

C. albicans

-

20

+

26

Burn

C. parapsilosis

-

20

+

27

Burn

C. albicans

-

2560

+

28

Burn

C. albicans

-

320

+

29

Abdominal surgery

C. albicans

-

160

+

30

Acute lymphocytic leukemia

C. albicans

-

20480

+

31

Acute myeloid leukemia

C. albicans

+

20480

+

32

Non-Hodgkin's lymphoma

C. parapsilosis

-

5120

+

33

Acute myeloid leukemia

C. krusei

-

0

-

34

Hepatosplenic candidiasis

C. albicans

-

1280

+

35

Chronic lymphocytic leukemia

C. albicans

-

20

-

36

Acute myeloid leukemia

C. albicans

+

320

+